163 related articles for article (PubMed ID: 24752338)
1. SOX2 oncogenes amplified and operate to activate AKT signaling in gastric cancer and predict immunotherapy responsiveness.
Tian Y; Jia X; Wang S; Li Y; Zhao P; Cai D; Zhou Z; Wang J; Luo Y; Dong M
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1117-24. PubMed ID: 24752338
[TBL] [Abstract][Full Text] [Related]
2. LMO1 is a novel oncogene in lung cancer, and its overexpression is a new predictive marker for anti-EGFR therapy.
Zhang Y; Yang J; Wang J; Guo H; Jing N
Med Oncol; 2014 Aug; 31(8):99. PubMed ID: 25037573
[TBL] [Abstract][Full Text] [Related]
3. LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.
Liu J; Yan P; Jing N; Yang J
Tumour Biol; 2014 Aug; 35(8):8161-7. PubMed ID: 24845030
[TBL] [Abstract][Full Text] [Related]
4. Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage.
Yang L; Xu JF; Kang Q; Li AQ; Jin P; Wang X; He YQ; Li N; Cheng T; Sheng JQ
PLoS One; 2017; 12(1):e0169124. PubMed ID: 28046028
[TBL] [Abstract][Full Text] [Related]
5. SOX2, a predictor of survival in gastric cancer, inhibits cell proliferation and metastasis by regulating PTEN.
Wang S; Tie J; Wang R; Hu F; Gao L; Wang W; Wang L; Li Z; Hu S; Tang S; Li M; Wang X; Nie Y; Wu K; Fan D
Cancer Lett; 2015 Mar; 358(2):210-219. PubMed ID: 25543086
[TBL] [Abstract][Full Text] [Related]
6. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.
Justilien V; Walsh MP; Ali SA; Thompson EA; Murray NR; Fields AP
Cancer Cell; 2014 Feb; 25(2):139-51. PubMed ID: 24525231
[TBL] [Abstract][Full Text] [Related]
7. SETD8 promotes stemness characteristics and is a potential prognostic biomarker of gastric adenocarcinoma.
Piao L; Che N; Li H; Li M; Feng Y; Liu X; Kim S; Jin Y; Xuan Y
Exp Mol Pathol; 2020 Dec; 117():104560. PubMed ID: 33127342
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of SOX2 is involved in paclitaxel resistance of ovarian cancer via the PI3K/Akt pathway.
Li Y; Chen K; Li L; Li R; Zhang J; Ren W
Tumour Biol; 2015 Dec; 36(12):9823-8. PubMed ID: 26159849
[TBL] [Abstract][Full Text] [Related]
9. AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation.
Wang Z; Kang L; Zhang H; Huang Y; Fang L; Li M; Brown PJ; Arrowsmith CH; Li J; Wong J
Oncogene; 2019 Jun; 38(26):5250-5264. PubMed ID: 30894683
[TBL] [Abstract][Full Text] [Related]
10. Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells.
Dorsett KA; Jones RB; Ankenbauer KE; Hjelmeland AB; Bellis SL
J Ovarian Res; 2019 Oct; 12(1):93. PubMed ID: 31610800
[TBL] [Abstract][Full Text] [Related]
11. The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells.
Hütz K; Mejías-Luque R; Farsakova K; Ogris M; Krebs S; Anton M; Vieth M; Schüller U; Schneider MR; Blum H; Wagner E; Jung A; Gerhard M
Carcinogenesis; 2014 Apr; 35(4):942-50. PubMed ID: 24325912
[TBL] [Abstract][Full Text] [Related]
12. IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling.
Wei CX; Wong H; Xu F; Liu Z; Ran L; Jiang RD
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8169-8178. PubMed ID: 30556855
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
14. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.
Wang N; She J; Liu W; Shi J; Yang Q; Shi B; Hou P
Cell Cycle; 2015; 14(5):732-43. PubMed ID: 25590580
[TBL] [Abstract][Full Text] [Related]
15. SOX2 inhibits metastasis in gastric cancer.
Chen Y; Huang Y; Zhu L; Chen M; Huang Y; Zhang J; He S; Li A; Chen R; Zhou J
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1221-30. PubMed ID: 26960758
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-371-5p targets SOX2 in gastric cancer.
Li YJ; Dong M; Kong FM; Zhou JP; Liang D; Xue HZ
Oncotarget; 2016 May; 7(22):31993-2005. PubMed ID: 27015119
[TBL] [Abstract][Full Text] [Related]
17. Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis.
Basati G; Mohammadpour H; Emami Razavi A
J Gastrointest Cancer; 2020 Mar; 51(1):41-47. PubMed ID: 30628031
[TBL] [Abstract][Full Text] [Related]
18. SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer.
Schaefer T; Steiner R; Lengerke C
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664542
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1.
Schaefer T; Ramadoss A; Leu S; Tintignac L; Tostado C; Bink A; Schürch C; Müller J; Schärer J; Moffa G; Demougin P; Moes S; Stippich C; Falbo S; Neddersen H; Bucher H; Frank S; Jenö P; Lengerke C; Ritz MF; Mariani L; Boulay JL
Brain Pathol; 2019 May; 29(3):336-350. PubMed ID: 30403311
[TBL] [Abstract][Full Text] [Related]
20. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
Gen Y; Yasui K; Nishikawa T; Yoshikawa T
Cancer Sci; 2013 Jul; 104(7):810-6. PubMed ID: 23510069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
